The antibacterial potential of F-AgNPs was calculated by their MICs against Staphylococcus aureus (MDR), Klebsiella pneumonia, Salmonella abony, and Escherichia coli (MDR). The bacterial strain was collected in the mid-logarithm phase and diluted to 2 × 105 CFU/mL in 0.03% of Luria-Bertani (LB) broth in PBS. The 100 μL of LB medium consist of F-AgNPs were serially diluted in 96 well plates [22]. The lowest concentration of F-AgNPs at which 25, 50, 75% growth of microbes was inhibited is defined as MIC25, MIC50, and MIC75, respectively. For negative control, Milli-Q water was used for each experiment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.